---
title: Bio-Synthesis, Inc. vs Sinopep-Allsino Biopharmaceutical Co., Ltd.
slug_a: biosyn
slug_b: sinopep
site: cdmo
review_signal_gate: closed
canonical_path: /compare/biosyn/sinopep
generated_by: BioBM Editorial AI
---

# Bio-Synthesis, Inc. vs Sinopep-Allsino Biopharmaceutical Co., Ltd.

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

Bio-Synthesis, Inc. (biosyn) is listed for cdmo. Custom DNA, RNA, siRNA, and ASO oligonucleotide synthesis, custom peptide manufacturing, and project-specific bioconjugation. Support extends from research through analytical QC, process development, and scale-up.

Services: 7. Modalities: 3. Indications: 0. Locations: 0. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (7).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

Sinopep-Allsino Biopharmaceutical Co., Ltd. (sinopep) is listed for cdmo. GMP peptide and oligonucleotide CDMO offering custom synthesis, NCE development, CMC manufacturing, and finished dosage form formulation services for therapeutic programs.

Services: 6. Modalities: 2. Indications: 0. Locations: 0. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (6).

Review summary: Review summary withheld until site-level review gate opens.